In addition to de novo lipid synthesis, cancer cells can also increase FA uptake from the extracellular interstitium through several plasma membrane proteins, including the LDL receptor and the FA translocase CD36, whose upregulation associates with poor prognosis in several types of cancers [59–62] (Fig. 1). Here, LDLR is linked to cancer.